000 02443 a2200673 4500
005 20250517011236.0
264 0 _c20150420
008 201504s 0 0 eng d
022 _a1527-7755
024 7 _a10.1200/JCO.2014.57.1745
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDang, Chau
245 0 0 _aPhase II study of paclitaxel given once per week along with trastuzumab and pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.
_h[electronic resource]
260 _bJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_cFeb 2015
300 _a442-7 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntibodies, Monoclonal, Humanized
_xadministration & dosage
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aBiomarkers, Tumor
_xanalysis
650 0 4 _aBreast Neoplasms
_xchemistry
650 0 4 _aDisease-Free Survival
650 0 4 _aDrug Administration Schedule
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aHumans
650 0 4 _aImmunohistochemistry
650 0 4 _aIn Situ Hybridization, Fluorescence
650 0 4 _aInfusions, Intravenous
650 0 4 _aKaplan-Meier Estimate
650 0 4 _aMiddle Aged
650 0 4 _aPaclitaxel
_xadministration & dosage
650 0 4 _aReceptor, ErbB-2
_xanalysis
650 0 4 _aTrastuzumab
650 0 4 _aTreatment Outcome
700 1 _aIyengar, Neil
700 1 _aDatko, Farrah
700 1 _aD'Andrea, Gabriella
700 1 _aTheodoulou, Maria
700 1 _aDickler, Maura
700 1 _aGoldfarb, Shari
700 1 _aLake, Diana
700 1 _aFasano, Julie
700 1 _aFornier, Monica
700 1 _aGilewski, Theresa
700 1 _aModi, Shanu
700 1 _aGajria, Devika
700 1 _aMoynahan, Mary Ellen
700 1 _aHamilton, Nicola
700 1 _aPatil, Sujata
700 1 _aJochelson, Maxine
700 1 _aNorton, Larry
700 1 _aBaselga, Jose
700 1 _aHudis, Clifford
773 0 _tJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_gvol. 33
_gno. 5
_gp. 442-7
856 4 0 _uhttps://doi.org/10.1200/JCO.2014.57.1745
_zAvailable from publisher's website
999 _c24495047
_d24495047